- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02236416
Physical Exercise for Prevention of Dementia (EPD)
July 19, 2021 updated by: Alfonso Di Costanzo, MD, University of Molise
Physical Exercise and Prevention of Cognitive Decline in Subjects at Risk of Dementia: a Randomized Controlled Trial
The principal aim of this study is to verify whether a program of supervised, multimodal physical exercise improves cognitive function and/or reduces the rate of cognitive decline in older adults
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Community-dwelling volunteers, recruited from social centers, were invited to an in-person assessment that included a medical history questionnaire and examination, anthropometric measurements, blood tests for cardiovascular risk, and several outcome measures.
Participants meeting the inclusion criteria were divided in 3 groups (participants without subjective or objective cognitive impairment, with subjective memory complaints and with mild cognitive impairments) and randomly assigned (1:1) to an experimental group or a control group, using a list of random numbers generated by a statistical software.
The list was kept in a sealed envelope and a researcher, not directly involved in the recruitment and in the evaluation of the participants, assigned the allocation numbers.
Study Type
Interventional
Enrollment (Actual)
1000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Molise
-
Campobasso, Molise, Italy, 86100
- Center for Research and Training in Medicine of Aging (CeRMA)
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
50 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
Age > 50 years old
Exclusion Criteria:
- Medical conditions that compromise survival or limit physical activity
- Geriatric Depression Scale-15 score of 6 or higher
- Alcohol intake > 4 units/day
- Mini- Mental State Examination < 24
- Clinical Dementia Rating score of 1 or more
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intervention group
Physical exercise
|
Supervised, multimodal physical activity including aerobic, resistance and stretching exercises
|
Other: Control group
Posture Education/Unchanged condition
|
Usual physical activity, generally consisting in long walks and/or stretching, toning and/or balance exercises, or posture education
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of Mini Mental State Examination (MMSE) score from baseline to 48 months
Time Frame: Baseline and every 6-12 months, over an intervention period of 48 months
|
Scale for grading cognitive function
|
Baseline and every 6-12 months, over an intervention period of 48 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of neuropsychological test battery from baseline to 48 months
Time Frame: Baseline and every 6 -12 months, over an intervention period of 48 months
|
It includes: Frontal Assessment Battery, Rey's Auditory Verbal Learning Test, Prose Memory, Stroop Color Word Interference Test, Attentive Matrices, Raven's Progressive Matrices, Trial Making Test, designs copying with and without programming models.
|
Baseline and every 6 -12 months, over an intervention period of 48 months
|
Change of Geriatric Depression Scale (GDS) from baseline to 48 months
Time Frame: Baseline and every 6 -12 months, over an intervention period of 48 months
|
A self-report assessment for identifing depression in the elderly
|
Baseline and every 6 -12 months, over an intervention period of 48 months
|
Change of Short-form Health Survey (SF-36) from baseline to 48 months
Time Frame: Baseline and every 6 -12 months, over an intervention period of 48 months
|
Assessment of health status
|
Baseline and every 6 -12 months, over an intervention period of 48 months
|
Change of Memory Complaint Questionnaire (MAC-Q) from baseline to 48 months
Time Frame: Baseline and every 6 -12 months, over an intervention period of 48 months
|
Assessment of subjective memory complaint
|
Baseline and every 6 -12 months, over an intervention period of 48 months
|
Change of Physical Activity Scale for the Elderly (PASE) from baseline to 48 months
Time Frame: Baseline and every 6 -12 months, over an intervention period of 48 months
|
Assessment of physical activity level in elderly
|
Baseline and every 6 -12 months, over an intervention period of 48 months
|
Change of AAHPERD (American Alliance for Health, Physical Education, Recreation and Dance) fitness test battery from baseline to 48 months
Time Frame: Baseline and every 6 -12 months, over an intervention period of 48 months
|
Functional fitness assessment
|
Baseline and every 6 -12 months, over an intervention period of 48 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change of Composite cognitive score (CCS) from baseline to 48 months
Time Frame: Baseline and every 6 -12 months, over an intervention period of 48 months
|
It is calculated by averaging the standardized scores (Z-score) of all neuropsychological tests, for assessing the overall changes in cognitive performance.
|
Baseline and every 6 -12 months, over an intervention period of 48 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Alfonso Di Costanzo, MD, University of Molise
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2011
Primary Completion (Actual)
July 1, 2020
Study Completion (Actual)
July 1, 2020
Study Registration Dates
First Submitted
September 3, 2014
First Submitted That Met QC Criteria
September 8, 2014
First Posted (Estimate)
September 10, 2014
Study Record Updates
Last Update Posted (Actual)
July 21, 2021
Last Update Submitted That Met QC Criteria
July 19, 2021
Last Verified
July 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21933_III/11
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aging
-
Tuba MadenCompletedAging | Aging Problems | Aging Disorder
-
Radboud University Medical CenterNot yet recruitingAging | Aging Well | Immuno Aging
-
University of Santiago de CompostelaEuropean Regional Development Fund; Center for Industrial Technological Development...Completed
-
TruDiagnosticBlushield USANot yet recruitingAging | Aging Well
-
San Diego State UniversityCompleted
-
Lithuanian Sports UniversityCompletedAging | Healthy AgingLithuania
-
University of West AtticaNot yet recruiting
-
University of Santiago de CompostelaAgencia Estatal de Investigación, SpainRecruiting
-
Beijing HospitalBGI-ShenzhenCompletedAging | Healthy Aging
-
Amazentis SAproDERM GmbHCompleted
Clinical Trials on Intervention group
-
Muğla Sıtkı Koçman UniversityNot yet recruiting
-
University of LiegeCentre Hospitalier Universitaire de Liege; Bial Foundation; FNRS (Télévie); Fondation...RecruitingPain | Cancer | Fatigue | Cognitive Impairment | Sleep Disturbance | Distress, EmotionalBelgium
-
Hospital de Clinicas de Porto AlegreUnknown
-
University of California, San FranciscoNational Cancer Institute (NCI); Cancer Prevention Institute of CaliforniaCompletedHereditary Breast and Ovarian Cancer Syndrome
-
University of Sao PauloCompletedAnxiety | Self Esteem
-
Haute Ecole de Santé VaudCompletedArthroplasty, Replacement, Knee | Arthroplasty, Replacement, HipSwitzerland
-
Azienda Ospedaliero-Universitaria CareggiRecruiting
-
University of North Carolina, Chapel HillNational Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases
-
University of OxfordOxford Brookes UniversityRecruitingOverweight/Obesity, AdolescentUnited Kingdom
-
Beijing Tsinghua Chang Gung HospitalRecruitingLifestyle Intervention | Non Communicable DiseasesChina